Rheumatoid Arthritis Completed Phase Trials for Adalimumab (DB00051)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02963402Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab
NCT02778789Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers
NCT02668640Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in China
NCT01736189Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice
NCT01768858Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
NCT03496831Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs
NCT01592292An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy
NCT00814866Bone Resorption, Osteoclastogenesis and AdalimumabBasic Science
NCT00497614Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)Treatment
NCT01078571Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
NCT01060098T Cells and TNF: The Impact of TNF Blockade
NCT01029613Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers